Jonathan C. Meltzer - 10 Feb 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer
Issuer symbol
LH
Transactions as of
10 Feb 2026
Net transactions value
-$25,188
Form type
4
Filing time
12 Feb 2026, 15:44:53 UTC
Previous filing
10 Feb 2026
Next filing
13 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meltzer Jonathan C EVP, Operations 531 SOUTH SPRING STREET, BURLINGTON /s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer 12 Feb 2026 0002103998

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Sale $25,188 -91 -3.3% $276.79 2,696 10 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Award $0 +1,900 $0.000000 1,900 10 Feb 2026 Common Stock 1,900 $284.50 Direct F2, F3
transaction LH Restricted Stock Unit Award $0 +620 +27% $0.000000 2,937 10 Feb 2026 Common Stock 620 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
F3 The option vests in three equal annual installments beginning on the date reflected in this column.
F4 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F5 The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
F6 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.